當(dāng)前位置：   首頁 > 需求大廳

文獻(xiàn)標(biāo)題: 1.Development and evaluation of chitosan based oral controlled matrix tablets of?losartan?potassium J Pharm Investig.?2012 Jul;2(3):157-61. doi: 10.4103/2230-973X.104399. 2.Response criteria of tolvaptan for the treatment of hepatic edema J Gastroenterol. 2017 Jun 29. 3.Hepatol Res.?2017 Oct 6. doi: 10.1111/hepr.12988. [Epub ahead of print] Increased?serum?C-reactive?protein?and?decreased?urinary?aquaporin?2?levels?are?predictive?of the?efficacy?of?tolvaptan?in?patients?with?liver?cirrhosis. 4.Highly linear pH gradients for analyzing monoclonal antibody charge heterogeneity in the alkaline range. 5.An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles 6.Anatol J Cardiol.?2017 Sep;18(3):213-214. doi: 10.14744/AnatolJCardiol.2017.8033. Tolvaptan?in the very elderly with acute decompensated heart failure- a therapeutic option worth of consideration. 7.紫外-可見分光光度法測(cè)定依達(dá)拉奉注射液中的亞硫酸氫鈉含量 8.Anatol J Cardiol. 2017 Sep;18(3):213-214. doi: 10.14744/AnatolJCardiol.2017.8033. Tolvaptan in the very elderly with acute decompensated heart failure- a therapeutic option worth of consideration. 備注: 將符合要求的文獻(xiàn)PDF格式打包上傳   [更多]

1. 請(qǐng)生物醫(yī)藥專利方面的高手按照要求撰寫技術(shù)類型分策略式。 2. 策略式：給某一類技術(shù)類型的專利打上標(biāo)記（如“化合物專利、晶型專利、制備方法專利等），從而通過策略式能把某一類專利檢索出來。 3.待撰寫的技術(shù)類型見附件，有投稿意愿的請(qǐng)下載瀏覽； 4.懸賞金額：每個(gè)策略式500元，獎(jiǎng)勵(lì)額不菲哈。 5.其他要求請(qǐng)加QQ或投稿后再詳談。   [更多]

文獻(xiàn)名稱: 1.Sodium Diisopropylamide in Tetrahydrofuran: Selectivities, Rates, and Mechanisms of Arene Metalations 2.Advances toward LSD1 inhibitors for cancer therapy　 3.Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer 4.Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder. 5.The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study. 6. G.A. Digenis, The in vivo behavior of multiparticulate versus single unit dose formulations, CAPSUGEL’s Symposium in Seoul, 1990. 7.Stability of salicylic acid and magnesium stearate by DSC 作者：L Macpherson ， S Sauerbrunn 出版源：《American Laboratory》 , 2006 , 38 (14) :16-20 備注 : 將符合要求的文獻(xiàn)PDF格式上傳   [更多]

文獻(xiàn)名稱: 1.A Systematic Review and Meta-analysis of Efficacy and Safety of Novel Interleukin Inhibitors in the Management of Psoriatic Arthritis. J Clin Rheumatol. 2017 Sep 19. 2.A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis.Immunotherapy. 2017 Sep;9(12):963-978 備注 : 將符合要求的文獻(xiàn)PDF格式上傳   [更多]

要求： 1. 熟悉PDF編輯技巧(去水印、去章印、增刪內(nèi)容) 2. 處理完221個(gè)PDF上面的水印標(biāo)記和部分與文章標(biāo)題無關(guān)的內(nèi)容，提交后待成品效果符合要求后才判為合格，否則為不合格任務(wù)（具體處理細(xì)則可以QQ咨詢） 3. 需處理的PDFE文檔待接下任務(wù)后再提供   [更多]

文獻(xiàn)名稱: 1.Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia. Am. J. Hematol. 2009, 84:422–427 2.15:05:49 憨出出 2017/10/11 15:05:49 EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis 3.Japan Guideline for treatment of chronic heart failure(JCS 2010) 備注: 將符合要求的文獻(xiàn)PDF格式打包上傳   [更多]

要求：1.熟悉圖片去水印方法。 2.處理完225張圖片上面的水印標(biāo)記，提交后待檢查效果達(dá)到要求后才判為合格，否則為不合格任務(wù)。 3.需處理的圖片待接下任務(wù)后再提供。   [更多]

求DOF（Drugs of the future）2017年第6、7兩期的文章（共17篇） 地址如下： https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_journal_home_pr?p_JournalID=2&p_VolumeID=42   [更多]

具體要求; 需要英國藥典標(biāo)準(zhǔn)“Appendix XII B. Monographs of the British Pharmacopoeia”《 BP2017 》的藥典標(biāo)準(zhǔn)一份.   [更多]

文獻(xiàn)名稱： 1、 A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids。British journal of Dermatology. Volume 157, Issue 5 November 2007 Pages 954-959 2、Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: Results from 3 randomized, comparative studies. JAAD. May 2005Volume 52, Issue 5, Pages 810-822 3、Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. BJD Volume 165, Issue 3 September 2011 Pages 465-473 4、 Comparative Effectiveness of Topical Calcineurin Inhibitors in Adult Patients with Atopic Dermatitis . American Journal of Clinical Dermatology.April 2012, Volume 13, Issue 2, pp 113-123 5、Alikani M, Fauser BCJ, García-Valesco JA, Simpson JL, Johnson MH. Response from the Editors: first birth following spindle transfer. Reprod Biomed Online. 2017 Jul 20. pii: S1472-6483(17)30308-5. doi: 10.1016/j.rbmo.2017.07.002. [Epub ahead of print] PubMed PMID: 28781009. 6、Alikani M, Fauser BCJ, García-Valesco JA, Simpson JL, Johnson MH. First birth following spindle transfer for mitochondrial replacement therapy: hope and trepidation. Reprod Biomed Online. 2017 Apr;34(4):333-336. doi: 10.1016/j.rbmo.2017.02.004. PubMed PMID: 28385333. 7、 Simpson JL. Reproducing genetics. Genet Med. 2015 Jun;17(6):512-4. doi: 10.1038/gim.2015.37. PubMed PMID: 26035802. 8、Wou K, Feinberg JL, Wapner RJ, Simpson JL. Cell-free DNA versus intact fetal cells for prenatal genetic diagnostics: what does the future hold? Expert Rev Mol Diagn. 2015;15(8):989-98. doi: 10.1586/14737159.2015.1051529. Epub 2015 May 31. Review. PubMed PMID: 26027684. 9、Zhao S, Li G, Dalgleish R, Vujovic S, Jiao X, Li J, Simpson JL, Qin Y, Ivanisevic M, Ivovic M, Tancic M, Al-Azzawi F, Chen ZJ. Transcription factor SOHLH1 potentially associated with   [更多]